Compare CCJ & TEVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CCJ | TEVA |
|---|---|---|
| Founded | 1987 | 1901 |
| Country | Canada | Israel |
| Employees | N/A | 32842 |
| Industry | Other Metals and Minerals | Biotechnology: Pharmaceutical Preparations |
| Sector | Basic Materials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 50.8B | 41.6B |
| IPO Year | 1998 | N/A |
| Metric | CCJ | TEVA |
|---|---|---|
| Price | $115.59 | $36.28 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 8 | 8 |
| Target Price | ★ $123.92 | $38.63 |
| AVG Volume (30 Days) | 3.1M | ★ 6.0M |
| Earning Date | 05-05-2026 | 04-29-2026 |
| Dividend Yield | ★ 0.15% | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $0.12 | N/A |
| Revenue Next Year | $12.11 | $2.97 |
| P/E Ratio | $118.32 | ★ $28.19 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $50.03 | $14.99 |
| 52 Week High | $135.24 | $37.35 |
| Indicator | CCJ | TEVA |
|---|---|---|
| Relative Strength Index (RSI) | 47.79 | 71.27 |
| Support Level | $109.59 | $30.53 |
| Resistance Level | $124.38 | $37.35 |
| Average True Range (ATR) | 6.05 | 1.05 |
| MACD | -0.68 | 0.19 |
| Stochastic Oscillator | 27.82 | 90.17 |
Cameco Corp is a provider of uranium needed to generate clean, reliable baseload electricity around the globe and is one of those uranium producers. It has three reportable segments: Uranium, Fuel Services, and Westinghouse, deriving maximum revenue from the Westinghouse segment. The Uranium segment involves the exploration for, mining, milling, purchase, and sale of uranium concentrate, while the Fuel Services segment involves the refining, conversion, and fabrication of uranium concentrate and the purchase and sale of conversion services. Westinghouse Electric Company provides products and services to nuclear reactors, including outage and maintenance services, engineering support, instrumentation and controls equipment, plant modification, and components and parts.
Teva Pharmaceutical, based in Israel, is the leading generic drug manufacturer in the world. Teva derives half of its sales from North America and makes up a high-single-digit percentage of the total number of generic prescriptions in the US. It also has a significant presence in Europe, Japan, Russia, and Israel. Besides generics, Teva has a portfolio of innovative medicines and biosimilars in three main therapeutic areas: the central nervous system with Copaxone, Ajovy, and Austedo; respiratory with Qvar and ProAir; and oncology with Truxima, Herzuma, and Bendeka/Treanda. Teva also sells active pharmaceutical ingredients, offers contract manufacturing services, and owns Anda, a US-based generic and specialty drug distributor.